Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
AMVUTTRA Revenue	1.77B	970.45M
ONPATTRO Revenue	197.21M	252.86M
GIVLAARI Revenue	286.34M	255.87M
OXLUMO Revenue	185.36M	167.05M
Total Product Revenue	2.44B	1.65B
Roche - Collaboration Revenue	373.94M	119.49M
Regeneron Pharmaceuticals - Collaboration Revenue	136.78M	302.80M
Novartis AG - Collaboration Revenue	-	79.76M
Other - Collaboration Revenue (Post-FY2022)	48.65M	8.18M
Total Collaboration Revenue	619.37M	510.22M
Royalty Revenue	148.04M	91.79M
Revenue (Other)	-559.37M	-510.22M
Revenue (Total)	3.21B	2.25B

Updated Sep 30, 2025. Data Source: Fiscal.ai.